2160 — MicroPort CardioFlow Medtech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.24bn
- HK$399.17m
- CNY336.22m
- 41
- 20
- 17
- 11
Annual cashflow statement for MicroPort CardioFlow Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -145 | -398 | -183 | -451 | — |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 18.7 | 249 | 24.4 | 170 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -32.7 | 15.4 | -46.6 | 17 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -143 | -110 | -162 | -183 | — |
| Capital Expenditures | -48.7 | -58.2 | -108 | -49.1 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6.97 | 1.8 | -329 | -131 | — |
| Acquisition of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -55.7 | -56.4 | -437 | -180 | — |
| Financing Cash Flow Items | -476 | -2.73 | -3.03 | 1.09 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 263 | 676 | 2,226 | -136 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 58.8 | 503 | 1,599 | -345 | — |